Evidence Hub

Phytochemical and In-SilicoAnalysis of the PotentAntidiabetic Compound from Cactus (Opuntia ficus–indica) cladode

S Vellaikumar, Saranya Nallusamy, P Preethieswari

Madras Agricultural Journal, 2025

Abstract

The present investigation aimed to identify the bioactive compounds inOpuntia ficus cladode and their pharmaceutical importance, which was evaluated through phytochemical and in-silico screening. The cladode’s phytochemical screening revealed alkaloids, tannins, flavonoids, phenols, proteins, terpenoids,glycosides, steroids, saponins etc. A total of 25 compounds were identified in the gas chromatography and mass spectrometry (GC-MS) analysis, and an active metabolite 2-Thophene carboxylic acid-5methyl was selected for in-silico docking study againstfour human protein targets namely, Human Estrogen receptor (PDB ID: 3ERT) (anti-cancer), HIV-1 envelope glycoprotein (PDB ID: 4CC8) (anti HIV), Human C-reactive protein (PDB ID: 1GNH) (anti-inflammation) and Human 11beta-hydroxysteroid dehydrogenase type I (11beta-HSD1) (PDB ID: 1XU7) (anti-diabetes) respectively via Schrodinger version 9.3. Among the four target proteins, the potent inhibition observed against Human 11beta-hydroxysteroid dehydrogenase type I (11beta-HSD1) (PDB ID: 1XU7) is involved in type 2 diabetes. Therefore, Opuntia ficuscladodes can be explored in managing type 2 diabetes.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free